Profile
Michael R.
Bristow is the founder of miRagen Therapeutics, Inc. (founded in 2007), Gilead Colorado, Inc. (founded in 1996), ARCA biopharma, Inc. (founded in 2004), and ARCA biopharma, Inc. (founded in 1992).
His current job is as a Professor at the University of Colorado Health Sciences Center, which he started in 1991.
His former job includes being a Director at TouchStone Research, Inc. He obtained his undergraduate and doctorate degrees from the University of Illinois.
Michael Bristow active positions
| Companies | Position | Start |
|---|---|---|
University of Colorado Health Sciences Center
University of Colorado Health Sciences Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 1991-09-30 |
Former positions of Michael Bristow
| Companies | Position | End |
|---|---|---|
| ARCA BIOPHARMA | Chief Executive Officer | 2024-04-02 |
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops genetic therapies for heart failure and cardiovascular diseases | Founder | 2009-01-26 |
TouchStone Research, Inc.
TouchStone Research, Inc. Miscellaneous Commercial ServicesCommercial Services Provides contract research services to pharmaceutical and medical device companies | Director/Board Member | 2007-10-22 |
Gilead Colorado, Inc.
Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs for cardiovascular diseases | Founder | 2006-01-31 |
miRagen Therapeutics, Inc. /Old/
miRagen Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops microRNA-based therapeutics for cardiovascular and muscle diseases | Founder | - |
Training of Michael Bristow
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Gilead Colorado, Inc.
Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs for cardiovascular diseases | Health Technology |
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops genetic therapies for heart failure and cardiovascular diseases | Health Technology |
miRagen Therapeutics, Inc. /Old/
miRagen Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops microRNA-based therapeutics for cardiovascular and muscle diseases | Health Technology |
University of Colorado Health Sciences Center
University of Colorado Health Sciences Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TouchStone Research, Inc.
TouchStone Research, Inc. Miscellaneous Commercial ServicesCommercial Services Provides contract research services to pharmaceutical and medical device companies | Commercial Services |
ARCA biopharma, Inc.
ARCA biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops genetic therapies for heart failure and cardiovascular diseases | Health Technology |
- Stock Market
- Insiders
- Michael Bristow
















